AMGN compared with SANA: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

SANASana Biotechnology, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

SANASana Biotechnology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only SANA 11

BEAMBeam Therapeutics, Inc. (Beam)supplier

—Flagship Pioneering Innovations V, Inc. (Flagship)unlistedsupplier

—FUJIFILM Cellular Dynamics, Inc. (FCDI)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

La Societe Pulsalys (Pulsalys)

unlistedsupplier

7 more · SANA chain ›

AMGNAmgen Inc

464.54▼−0.19%

Mkt cap$251.6BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

SANASana Biotechnology, Inc.

2.46▲+2.50%

Regular sessionNov 3 '26

Mkt cap$718.5MRevenue—Revenue—

Compare

Regular sessionNov 3 '26

AMGNAmgen Inc

SANASana Biotechnology, Inc.

464.54▼−0.19%

Price

2.46▲+2.50%

$251.6B

Mkt cap

$718.5M

Q2 FY26$10.1B

Revenue

—

FY25$36.8B

Revenue

—

AMGN464.54▼−0.19%vsSANA2.46▲+2.50%Regular sessionNov 3 '26